Beneficiary Name : KASHISH BHOJRAJ GUJARKAR
Contact No : 9158784900 Date Of Screening : 15/01/2025
Age (Yr) : 16 Gender : Male
Height (cm) : 170 Weight (Kg) : 48
Registration Number : 324630049044 Relation With Registered Worker : Son
Register Worker Name : BHOJRAJ RAMAJI GUJARKAR
District : Wardha Taluka : Deoli Pincode : 442101
Address : House No.,Nadeoli,Deoli S.O (Wardha),Deoli,Wardha,Maharashtra,442101
Blood Pressure :
Systolic : 117.00 (mmHg) Diastolic : 74.00 (mmHg)
Random Sugar : 98 mg/dL
Health History :
NIL
Pathology Investigation:
Sr No. Test Result
1 CBC, ESR, Malaria-Parasite Report Attached
2 LFT, KFT, Lipid Profile, Iron, Magnesium, RA, GGT Report Attached
3 Thyroid Profile, Vitamin B12 & D3, CEA Report Attached
4 HIV, HBV, HCV, VDRL Report Attached
Audiometry Test:
Right Ear : Normal Hearing Left Ear : Normal Hearing
Vision Test :
Right Eye Left Eye
Snellen Chart Reports : 6/6 6/6
Normal Vision Normal Vision
Near Vision : N5 N5
Observation : Normal Vision Normal Vision
CWH00007334840 D2D Camp / 327316 / 15 Jan 25 Page No - 1
Lung Function Test : Test Result : NORMAL
FVC (Litre) FEV1 (Litre) FEV1/FVC (%)
0.94 0.91 96.81
Post Camp Recommendation :
1) Observation - Elevated Uric acid levels,Insufficiency of vitamin D
2) Kindly correlate clinically and follow-up
3) Clinical Recommendations - Normal
Dr. Sonali Nimbalkar
Registration No : 30613A1
CWH00007334840 D2D Camp / 327316 / 15 Jan 25 Page No - 2
Patient Name : KASHISH BHOJRAJ GUJARKAR Registered On : 15/01/2025 10:05 pm
Patient Id : CWH00007334840 Reported On : 16/01/2025 06:58 pm
Age/Gender : 16Y/MALE Customer Name : MBOCWWB
Complete Blood Count
Investigation Result Units Biological Reference Interval
Hemoglobin (Hb) 13.6 gm/dl 13.0 - 17.0
Total RBC Count 4.4 Millions/Cumm 4.5 - 5.5
PCV 41.2 % 40 - 50
MCV 93.7 fL 83 - 101
MCH 31 Pg 27 - 32
MCHC 33.1 g/dL 31.5 - 34.5
RDW-CV 16.9 % 11.6 - 14.0
Total Leucocyte Count(TLC) 6790 Cells/Cumm 4000 - 10000
DIFFERENTIAL COUNT
Polymorphs 50 % 40 - 80
Lymphocytes 42 % 20 - 40
Monocytes 7 % 2 - 10
Eosinophils 1 % 1-6
Basophils 0 % 0-2
Platelet Count 2.67 Lakhs/Cumm 1.5 - 4.1
• Sample Type: EDTA Whole Blood.
• Method: Fully automated Hematology analyzer.
• Hb: Colorimetric, Total WBC: Impedence, Diff count: Calculated.RBC: Impedence
• HCT,MCV,MCHC,RDW-CV calculated. Platelets: Impedence Method.
--End Of Report--
Dr. Shilpa Sable
Processed At : HINDLAB, C/O Miss. Sarita Chakole, Near Kala Maroti Mandir, Sudampuri, Shiwaji Square,Wardha
- 442001
Page No - 3
Patient Name : KASHISH BHOJRAJ GUJARKAR Registered On : 15/01/2025 10:05 pm
Patient Id : CWH00007334840 Reported On : 16/01/2025 07:01 pm
Age/Gender : 16Y/MALE Customer Name : MBOCWWB
Hematology
Investigation Result Units Biological Reference Interval
Erythrocyte Sedimentation Rate 21 mm/hr 0 - 20
• Sample Type : EDTA Whole Blood.
• Method : Westergren
Malaria Parasite Negative
• Sample Type : EDTA Whole Blood.
• Method : Immunochromatography.
*Remark: It is a screening test. Negative result does not rule out possibility of Malaria.
--End Of Report--
Dr. Shilpa Sable
Processed At : HINDLAB, C/O Miss. Sarita Chakole, Near Kala Maroti Mandir, Sudampuri, Shiwaji Square,Wardha
- 442001
Page No - 4
Patient Name : KASHISH BHOJRAJ GUJARKAR Registered On : 15/01/2025 10:05 pm
Patient Id : CWH00007334840 Reported On : 21/01/2025 12:28 pm
Age/Gender : 16Y/MALE Customer Name : MBOCWWB
Liver Function Test
Investigation Result Units Biological Reference Interval
Serum Bilirubin, Total 0.37 mg/dL 0.3 - 1.2
• Sample Type : Serum.
• Method : Modified TAB method.
Serum Bilirubin, Direct 0.14 mg/dL < 0.4
• Sample Type: Serum.
• Method: Diazo.
Serum Bilirubin, Indirect 0.23 mg/dL < 0.9
• Method: Calculated
Serum SGOT 17 U/L < 46
• Sample Type: Serum.
• Method : IFCC
Serum SGPT 16 U/L < 49
• Sample Type: Serum.
• Method : IFCC
Serum Alkaline Phosphatase 132.57 U/L 180 - 1200
• Sample Type : Serum.
• Method : DGKC-SCE.
Serum Total Protein 8.16 g/dL 6.0 - 8.0
• Sample Type : Serum.
• Method: Direct Biuret Method.
Serum Albumin 4.41 g/dL 3.2 - 4.5
• Sample Type : Serum.
• Method: Bromocresol Green Method.
Serum Globulin 3.75 g/dL 2.0 - 3.5
• Method: Calculated.
Sample Type : SERUM
Method : IFCC WITHOUT PYRIDOXAL PHOSPHATE
--End Of Report--
Dr. Ajay Marawar
MBBS, MD Pathology
Processed At : PLOT NO A/45,Back side of Indorama Gate No-1,MIDC BUTIBORI,Beside Triveni Wires Nagpur-
441122 Maharashtra India
Page No - 5
Patient Name : KASHISH BHOJRAJ GUJARKAR Registered On : 15/01/2025 10:05 pm
Patient Id : CWH00007334840 Reported On : 21/01/2025 12:28 pm
Age/Gender : 16Y/MALE Customer Name : MBOCWWB
Biochemistry
Investigation Result Units Biological Reference Interval
Serum Iron 67.8 µg/dL 59 - 158
• Sample Type: Serum
• Method: Chromazurol Method
Serum Magnesium 1.98 mg/dL 1.6 - 2.6
• Sample Type : Serum.
• Method : Xylidyl Blue with ATCS.
Serum Calcium 9.77 mg/dL 8.8 - 10.2
• Sample Type : Serum.
• Method: Arsenazo III Method, End point.
Gamma Glutamyl Transferase (GGT) 22 U/L < 73
Sample Type: Serum
Method: Modified IFCC
Interpretation:
High levels of GGT indicates liver disease or damage
to the bile ducts.
Rheumatoid Factor (RA) 2.5 IU/mL < 18
Sample Type: Serum
Method: Latex enhanced Immunoturbidimetry
Sample Type : SERUM
Method : Xylidyl Blue with ATCS
--End Of Report--
Dr. Ajay Marawar
MBBS, MD Pathology
Processed At : PLOT NO A/45,Back side of Indorama Gate No-1,MIDC BUTIBORI,Beside Triveni Wires Nagpur-
441122 Maharashtra India
Page No - 6
Patient Name : KASHISH BHOJRAJ GUJARKAR Registered On : 15/01/2025 10:05 pm
Patient Id : CWH00007334840 Reported On : 21/01/2025 12:28 pm
Age/Gender : 16Y/MALE Customer Name : MBOCWWB
Renal Function Test
Investigation Result Units Biological Reference Interval
Serum Blood Urea 18.55 mg/dL 10 - 50
• Sample Type: Serum
• Method: UREASE/GLDH methodology.
BUN-Blood Urea Nitrogen 8.66 mg/dL 6 - 20
• Method: Calculated.
Serum Creatinine 0.86 mg/dL 0.3 - 0.7
• Sample Type : Serum.
• Method : Modified Jaffes Method.
Serum Uric Acid 5.84 mg/dL 2.0 - 5.0
• Sample Type : Serum.
• Method: Uricase-PAP Method
Sample Type: Serum
Method: Modified Jaffes Method
--End Of Report--
Dr. Ajay Marawar
MBBS, MD Pathology
Processed At : PLOT NO A/45,Back side of Indorama Gate No-1,MIDC BUTIBORI,Beside Triveni Wires Nagpur-
441122 Maharashtra India
Page No - 7
Patient Name : KASHISH BHOJRAJ GUJARKAR Registered On : 15/01/2025 10:05 pm
Patient Id : CWH00007334840 Reported On : 21/01/2025 12:28 pm
Age/Gender : 16Y/MALE Customer Name : MBOCWWB
Lipid Profile
Investigation Result Units Biological Reference Interval
Serum Total Cholesterol 120.58 mg/dL Desirable: <= 200
Borderline high risk: 200-240
High Risk: >240
• Sample Type : Serum.
• Method : CHOD-PAP Methodlogy.
Serum Triglycerides 105 mg/dL 60 - 165
• Sample Type : Serum.
• Method: GPO-TOPS Methodology.
Serum VLDL-Cholesterol 21.00 mg/dl 10.0 - 35.0
• Method: Calculated.
Serum HDL-Cholesterol 37.97 mg/dL 35 - 80
• Sample Type: Serum.
• Method: Selective Inhibition Method
LDL Cholesterol 61.61 mg/dL Desirable < 130
Borderline 130-159
High Risk for CHD > 160
• Sample Type : Serum
• Method : Selective Solubilisation Method
Sample Type : SERUM
Method : CHOD- PAP METHODLOGY
--End Of Report--
Dr. Ajay Marawar
MBBS, MD Pathology
Processed At : PLOT NO A/45,Back side of Indorama Gate No-1,MIDC BUTIBORI,Beside Triveni Wires Nagpur-
441122 Maharashtra India
Page No - 8
Patient Name : KASHISH BHOJRAJ GUJARKAR Registered On : 15/01/2025 10:05 pm
Patient Id : CWH00007334840 Reported On : 21/01/2025 02:03 pm
Age/Gender : 16Y/MALE Customer Name : MBOCWWB
Thyroid Function Test
Investigation Result Units Biological Reference Interval
Serum T3 1.04 ng/mL 0.87 - 1.78
Serum T4 6.00 ng/mL 6.09 - 12.23
Serum TSH 3.41 uiu/mL 0.28 - 3.89
• Sample Type: Serum.
• Method: CLIA.
Interpretation:
1) In pregnancy there is an alteration in thyroid hormone production and metabolism.
2) Useful for screening of thyroid illness, primary/secondary hypo-or hyperthyroidism, and also for monitoring patients with thyroid
replacement therapy.
• Please correlate with clinical conditions.
*References from Wallach’s Interpretation of Diagnostic Tests. (10th edition).
--End Of Report--
Dr. Ajay Marawar
MBBS, MD Pathology
Processed At : PLOT NO A/45,Back side of Indorama Gate No-1,MIDC BUTIBORI,Beside Triveni Wires Nagpur-
441122 Maharashtra India
Page No - 9
Patient Name : KASHISH BHOJRAJ GUJARKAR Registered On : 15/01/2025 10:05 pm
Patient Id : CWH00007334840 Reported On : 21/01/2025 02:03 pm
Age/Gender : 16Y/MALE Customer Name : MBOCWWB
Immunoassay
Investigation Result Units Biological Reference Interval
Vitamin B12 (Cyanocobalamin) 218.00 pg/mL 180 - 914
Deficient<145
• Sample Type: Serum
• Method: CLIA.
• Comments: Vitamin B12 performs many important functions in the body, but the most significant function is to act as a coenzyme
for reducing ribonucleotides to deoxyribonucleotides, a step in the formation of genes.
• Decreased Levels:
1. Lack of Intrinsic factor: Total or partial gastrostomy, Atrophic gastritis, Intrinsic factor antibodies.
2. Malabsorption: Regional ileitis, resected bowel, Tropical Sprue, Celiac disease, pancreatic insufficiency, bacterial overgrowth &
achlorhydria.
--End Of Report--
Dr. Ajay Marawar
MBBS, MD Pathology
Processed At : PLOT NO A/45,Back side of Indorama Gate No-1,MIDC BUTIBORI,Beside Triveni Wires Nagpur-
441122 Maharashtra India
Page No - 10
Patient Name : KASHISH BHOJRAJ GUJARKAR Registered On : 15/01/2025 10:05 pm
Patient Id : CWH00007334840 Reported On : 21/01/2025 02:03 pm
Age/Gender : 16Y/MALE Customer Name : MBOCWWB
Immunoassay
Investigation Result Units Biological Reference Interval
Vitamin-D (Total) 19.94 ng/mL Deficiency <10
Insufficiency 10-30
Sufficiency 30-100
Toxicity >100
• Sample type: Serum
• Method: CLIA.
• Interpretation:
1.Vitamin D is a lipid-soluble steroid hormone that is produced in the skin through the action of sunlight or is obtained from dietary
sources.
2.Vitamin D inadequacy may lead to secondary hyperparathyroidism, increased bone turnover, and progressive bone loss, increasing
the risk of osteoporosis.
3.Studies have associated vitamin D deficiency with an increased risk of cancer, autoimmune disease, infectious diseases,
cardiovascular diseases, and many chronic diseases.
--End Of Report--
Dr. Ajay Marawar
MBBS, MD Pathology
Processed At : PLOT NO A/45,Back side of Indorama Gate No-1,MIDC BUTIBORI,Beside Triveni Wires Nagpur-
441122 Maharashtra India
Page No - 11
Patient Name : KASHISH BHOJRAJ GUJARKAR Registered On : 15/01/2025 10:05 pm
Patient Id : CWH00007334840 Reported On : 21/01/2025 02:03 pm
Age/Gender : 16Y/MALE Customer Name : MBOCWWB
Immunoassay
Investigation Result Units Biological Reference Interval
Cancer & Tumor Marker - CEA 1.23 ng/ml Non Smoker <2.5
Smoker >5.0
• Sample Type: Serum.
• Method: ECLIA.
• Interpretation:
1.Carcinoembryonic antigen (CEA) is an oncofetal glycoprotein that is normally expressed by mucosal cells. It is overexpressed by a
variety of malignancies. Although it is most commonly associated with colorectal cancer.
2.It can also be elevated in other malignancies such as breast, liver, stomach, and pancreas.
3.There are a number of benign conditions that may lead to elevations in serum CEA level including cigarette smoking,
pancreatitis, biliary obstruction, peptic ulcer disease, and hypothyroidism, but the extent of elevation is substantially less, and it is
rare to see an elevation of >10 ng/ml in this context.
4.CEA is not an effective marker for hidden (occult) malignancy, since early tumors do not cause significant blood elevation.
5.A single test is difficult to evaluate but the number of tests done weeks apart show the trend in disease progression or regression.
6.Most important clinical application of CEA is its prognostic significance with colorectal cancer and its metastasis.
• Please correlate with clinical conditions.
--End Of Report--
Dr. Ajay Marawar
MBBS, MD Pathology
Processed At : PLOT NO A/45,Back side of Indorama Gate No-1,MIDC BUTIBORI,Beside Triveni Wires Nagpur-
441122 Maharashtra India
Page No - 12
Patient Name : KASHISH BHOJRAJ GUJARKAR Registered On : 15/01/2025 10:05 pm
Patient Id : CWH00007334840 Reported On : 16/01/2025 06:56 pm
Age/Gender : 16Y/MALE Customer Name : MBOCWWB
Serology
Investigation Result
HIV Rapid Test NON REACTIVE
• Sample Type: Serum
• Method: Immunochromatography.
• Clinical Significance: Human Immunodeficiency virus (HIV) testing determines whether you're infected with HIV, a virus that
weakens the immune system and can lead to AIDS.
• Note: It is a screening test, some serum components as well as other conditions may show cross-reactivity with HIV antibodies.
.
--End Of Report--
Dr. Shilpa Sable
Processed At : HINDLAB, C/O Miss. Sarita Chakole, Near Kala Maroti Mandir, Sudampuri, Shiwaji Square,Wardha
- 442001
Page No - 13
Patient Name : KASHISH BHOJRAJ GUJARKAR Registered On : 15/01/2025 10:05 pm
Patient Id : CWH00007334840 Reported On : 16/01/2025 06:56 pm
Age/Gender : 16Y/MALE Customer Name : MBOCWWB
Serology
Investigation Result
HBsAg (Hepatitis B antigen) test NON REACTIVE
• Sample Type: Serum
• Method: Rapid Immunochromatography.
• Kindly note this is a screening test. Kindly confirm this result by ELISA method.
• Clinical Significance: This assay is useful for the diagnosis of acute, recent and chronic HBV infection. It also determines the
chronic Hepatitis B infection status. It is the first serologic marker to appear in the serum at 6 to 16 weeks following exposure to
HBV. It usually disappears1 to 2 months after the onset of symptoms. Persistence >6 months indicates chronic carrier state or
chronic HBV infection.
• Please correlate with clinical conditions.
--End Of Report--
Dr. Shilpa Sable
Processed At : HINDLAB, C/O Miss. Sarita Chakole, Near Kala Maroti Mandir, Sudampuri, Shiwaji Square,Wardha
- 442001
Page No - 14
Patient Name : KASHISH BHOJRAJ GUJARKAR Registered On : 15/01/2025 10:05 pm
Patient Id : CWH00007334840 Reported On : 16/01/2025 06:56 pm
Age/Gender : 16Y/MALE Customer Name : MBOCWWB
Serology
Investigation Result
HCV-Rapid Test NON REACTIVE
• Sample Type: Serum.
• Method: Immunochromatography.
• Clinical Significance: Hepatitis C is a liver disease caused by the hepatitis C virus (HCV). The patient may develop liver cirrhosis
and/or liver cancer in severe infections. It is transmitted primarily through transfusion of infected blood, sharing of infected
needles, and through sexual transmission.
• Note: It is a screening test, Patient's having auto-immune liver diseases may give false positive results.
--End Of Report--
Dr. Shilpa Sable
Processed At : HINDLAB, C/O Miss. Sarita Chakole, Near Kala Maroti Mandir, Sudampuri, Shiwaji Square,Wardha
- 442001
Page No - 15
Patient Name : KASHISH BHOJRAJ GUJARKAR Registered On : 15/01/2025 10:05 pm
Patient Id : CWH00007334840 Reported On : 16/01/2025 06:56 pm
Age/Gender : 16Y/MALE Customer Name : MBOCWWB
Serology
Investigation Result
VDRL Rapid Test NON REACTIVE
• Sample Type : Serum.
• Method : Immunochromatography.
• Clinical Significance : Rapid Syphilis Antibody test is an immunoassay for the rapid and visual detection of antibodies to
Treponema Pallidum in human serum or plasma to aid in the diagnosis of Syphilis.
• Limitations : The test provides the presumptive diagnosis of Syphilis. A confirmed Syphilis diagnosis should only be made
by a physician after all clinical and laboratory findings have been evaluated.
• It is a screening tests, kindly correlate further with confirmatory tests in consultation with doctor.
--End Of Report--
Dr. Shilpa Sable
Processed At : HINDLAB, C/O Miss. Sarita Chakole, Near Kala Maroti Mandir, Sudampuri, Shiwaji Square,Wardha
- 442001
Page No - 16
